Gsquad Vector System: Vector construction with elegance and confidence

Introducing the new GSquad® vector system that streamlines construction of your GS piggyBac® vectors.

You may also be interested in:

Author(s):

Peter O'Callaghan, Ph.D.
Head of Expression System Sciences

First Name Last Name Business Email Company Name Country

State

Join our community to receive tailored insights and resources. You can unsubscribe at any time.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

Webinar (on-demand)

Outsourced Pharma Capacity Update - February 2025

Explore Lonza Biologics' end-to-end Drug Product capabilities along the full life cycle, seamlessly...

CDMO Notes Blog post

A Faster Path to the Clinic: Accelerating Biologics Development with Integrated Solutions

How Lonza’s team are helping to revolutionise the path to Biologics INDs, with an accelerated...

A View On mRNA Encapsulation (S04 E03)

In this episode, we are joined by three experts—Christoph Hein (Fraunhofer IPK), Bern-hard Bobusch...

From Discovery to Patients: an Integrated Service for ADC Development by Lonza and Synaffix

This white paper provides an in-depth look at the development and challenges of antibody-drug...

Webinar (on-demand)

Charting a Successful CMC Journey for Your ADC Drug Product

Bioconjugates and Antibody drug conjugates (ADCs) are revolutionizing cancer therapy with their...

ADC vial with gradient background - close crop

Expert Q&A: Accelerate Your ADC Journey

Filling the Need for Integrated Bioconjugate Solutions Antibody drug conjugates (ADCs) are...

KC Video thumbnail

mRNA and LNP Encapsulation Capabilities at our Geleen/NL Center of Excellence

Discover how our team, with its impressive mRNA/LNP track record, can help you progress your...

Mammalian Biologics Drug Substance Manufacture MC1

How Emerging Biotechs can Benefit by Partnering with a CDMO for Early Stage Development

The partnership between CDMOs and emerging biotech companies in early-stage development can be...

A View On Antibody-Based Therapies (S04 E02)

In this episode, we are joined by Ronnie Wei, Head of Biologics Discovery and Devel-opment at ModeX...

Webinar (on-demand)

Early Preclinical Development of mRNA/LNP Projects, Transitioning Successfully to cGMP...

View our on-demand webinar exploring the development steps that lead to an mRNA construct optimized...

Webinar (on-demand)

Enhanced GS® CHO Vector Technology for Improved Expression Control of Biotherapeutic Proteins

Many of today’s expression platforms for recombinant protein production have been optimised for the...

man working with microscope in lab,Process Development,Biologics_Slough_18,,lab in slough,tech working in lab with computer,male tech pipetting,tech holding vial,tech working,Cell Iine process development,biologics lab worker, ,Biologics_Slough_29,Biologics , Biologics Slough

Webinar (on-demand)

Integrating a High Sensitivity Immunopeptidomics (MAPPs) Assay in Preclinical Immunogenicity Risk...

Immunogenicity poses a critical risk to all biologics, including monoclonal antibodies, ADCs,...